Voyager Therapeutics, Inc. (VYGR)
3.42
-0.03
(-0.87%)
USD |
NASDAQ |
Sep 01, 16:00
3.42
0.00 (0.00%)
After-Hours: 16:30
Voyager Therapeutics Market Cap : 209.55M for Sept. 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 31, 2026 | 211.39M |
| August 28, 2026 | 216.91M |
| August 27, 2026 | 212.01M |
| August 26, 2026 | 212.01M |
| August 25, 2026 | 213.23M |
| August 24, 2026 | 210.78M |
| August 21, 2026 | 207.72M |
| August 20, 2026 | 203.43M |
| August 19, 2026 | 208.94M |
| August 18, 2026 | 202.20M |
| August 17, 2026 | 197.91M |
| August 14, 2026 | 200.36M |
| August 13, 2026 | 197.30M |
| August 12, 2026 | 196.07M |
| August 11, 2026 | 196.07M |
| August 10, 2026 | 194.24M |
| August 07, 2026 | 200.36M |
| August 06, 2026 | 191.79M |
| August 05, 2026 | 189.95M |
| August 04, 2026 | 191.48M |
| August 03, 2026 | 180.93M |
| July 31, 2026 | 182.74M |
| July 30, 2026 | 188.77M |
| July 29, 2026 | 180.93M |
| July 28, 2026 | 183.34M |
| Date | Value |
|---|---|
| July 27, 2026 | 186.36M |
| July 24, 2026 | 186.96M |
| July 23, 2026 | 186.36M |
| July 22, 2026 | 186.96M |
| July 21, 2026 | 189.38M |
| July 20, 2026 | 183.95M |
| July 17, 2026 | 191.18M |
| July 16, 2026 | 183.34M |
| July 15, 2026 | 192.99M |
| July 14, 2026 | 190.58M |
| July 13, 2026 | 195.41M |
| July 10, 2026 | 207.47M |
| July 09, 2026 | 221.94M |
| July 08, 2026 | 224.96M |
| July 07, 2026 | 227.97M |
| July 06, 2026 | 218.32M |
| July 02, 2026 | 227.97M |
| July 01, 2026 | 217.12M |
| June 30, 2026 | 211.09M |
| June 29, 2026 | 215.91M |
| June 26, 2026 | 216.51M |
| June 25, 2026 | 214.10M |
| June 24, 2026 | 221.94M |
| June 23, 2026 | 223.15M |
| June 22, 2026 | 224.36M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 340.29M |
| Amgen, Inc. | 236.86B |
| Anika Therapeutics, Inc. | 283.59M |
| BioCryst Pharmaceuticals, Inc. | 2.532B |
| Imunon, Inc. | 7.390M |
Market Cap Related Metrics
| PS Ratio | 5.900 |
| Price to Book Value | 1.357 |
| Price | 3.42 |
| Earnings Yield | -53.02% |